🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

GLOBAL MARKETS-Equities hover near record highs as stimulus hopes build

Published 03/12/2020, 04:04 am
Updated 03/12/2020, 04:06 am
© Reuters.
XAU/USD
-
US500
-
DJI
-
PFE
-
DX
-
GC
-
LCO
-
CL
-
ADP
-
IXIC
-
US10YT=X
-
MIWD00000PUS
-

(Updates through midday U.S. trading)

By David Randall

NEW YORK, Dec 2 (Reuters) - World equity benchmarks hovered near record highs and the dollar remained near 2-1/2-year lows on Wednesday as investors weighed the first approval of a coronavirus vaccine and the prospects for more U.S. economic stimulus with disappointing American jobs data.

Britain approved Pfizer (NYSE:PFE)'s PFE.N COVID-19 vaccine on Wednesday, jumping ahead of the United States and Europe to become the first country to do so for the newly developed treatment. Inoculations should begin among the most vulnerable segments of its population early next week. health officials have announced plans to start vaccinating Americans as early as mid-December, once regulatory approvals are in place. vaccines will help bolster the reflation and normalcy trade, which has been the key macro theme in driving equity markets," said Neil MacKinnon, global macro strategist at VTB Capital.

Yet, disappointing private jobs data in the United States kept a lid on gains and helped support safe-haven assets. Employers added 307,000 jobs last month, well below the 410,000 expected by economists polled by Reuters, according to the ADP (NASDAQ:ADP) National Employment Report. dollar index =USD fell 0.01%, while U.S. benchmark 10-year notes US10YT=RR last fell 4/32 in price to yield 0.9476%, from 0.934% Tuesday.

MSCI's gauge of stocks across the globe .MIWD00000PUS gained 0.13% following modest gains in Asia and mixed trading in Europe.

In midday trading on Wall Street, the Dow Jones Industrial Average .DJI fell 5.94 points, or 0.02%, to 29,817.98, the S&P 500 .SPX gained 1.7 points, or 0.05%, to 3,664.15 and the Nasdaq Composite .IXIC dropped 22.65 points, or 0.18%, to 12,332.46.

U.S. stock benchmarks closed at record highs on Tuesday.

"General risk sentiment is unchanged - perhaps there's a bit of consolidation today but that's understandable given where we've come from since November," said Derek Halpenny, EMEA head of research for global markets at MUFG. The dollar lost more than 2.5% of its value in November.

Markets were buoyed on Tuesday after top U.S. Senate Republican Mitch McConnell said that Congress should include new coronavirus stimulus in a $1.4 trillion spending bill aimed at heading off a government shutdown in the midst of the pandemic. President-elect Joe Biden told the New York Times his priority is getting a generous aid package through Congress even before he takes office in January. gold XAU= added 0.8% to $1,828.56 an ounce. U.S. gold futures GCc1 gained 0.68% to $1,826.40 an ounce.

U.S. crude CLc1 recently rose 2.24% to $45.55 per barrel and Brent LCOc1 was at $48.31, up 1.88% on the day.

Oil has raced up nearly 30% over the last month.

<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ Global assets

http://tmsnrt.rs/2jvdmXl Global currencies vs. dollar

http://tmsnrt.rs/2egbfVh Emerging markets

http://tmsnrt.rs/2ihRugV MSCI All Country Wolrd Index Market Cap

http://tmsnrt.rs/2EmTD6j

^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.